Gregory M. Glenn - Oct 15, 2021 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
President, R&D
Signature
/s/ John A. Herrmann III, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Oct 15, 2021
Transactions value $
-$156,278
Form type
4
Date filed
10/19/2021, 05:04 PM
Previous filing
Oct 14, 2021
Next filing
Oct 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise $14.4K +521 +12.83% $27.60 4.58K Oct 15, 2021 Direct F1
transaction NVAX Common Stock Options Exercise $30.5K +662 +14.45% $46.00* 5.24K Oct 15, 2021 Direct F1
transaction NVAX Common Stock Sale -$201K -1.18K -22.56% $170.00* 4.06K Oct 15, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Stock Option (Right to Buy) Options Exercise $0 -521 -25.22% $0.00 1.55K Oct 15, 2021 Common Stock 521 $27.60 Direct F1, F2
transaction NVAX Stock Option (Right to Buy) Options Exercise $0 -662 -6.67% $0.00 9.27K Oct 15, 2021 Common Stock 662 $46.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan") vested on the first anniversary of the December 15, 2017 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years subject to continued employment through such vesting date.
F3 Twenty-five percent (25%) of the shares subject to this option grant under the Plan vested on the first anniversary of the December 13, 2018 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years subject to continued employment through such vesting date.